Today

Agents

Chat

Arena

Discover

More

App

Anika Therapeutics Q2 Revenue USD 32.61 Million - ANIK News | Rallies

Anika Therapeutics Q2 Revenue USD 32.61 Million

ANIK•2026-07-29

Q2 financial results

Jul 29 (Reuters) - Anika Therapeutics Q2 revenue was USD 32.61 million.

Q2 gross profit: USD 21.244 million
Q2 pretax profit: USD 3.38 million
Q2 net income: USD 3.309 million
Q2 income from operations: USD 2.954 million

Related News

MGP Ingredients Q2 FY26 net income falls 16.67% to US$ 12 million; net sales drop 15% to US$ 124.4 million

MGPI•2026-07-29

Potomac Bancshares Q2 net income rises on loan growth; lifts dividend

PTBS•2026-07-29

NextEra, Brookfield To Build $100 Billion Kentucky Data Campus - Bloomberg News

NEE

•

2026-07-29

US Stocks-S&P 500, Nasdaq futures edge higher ahead of Fed decision; chip stocks wobble

SPY•2026-07-29

Southern Michigan Bancorp Q2 net income falls on real estate write-down

SOMC•2026-07-29